The Vigabatrin Risk Evaluation and Mitigation Strategy (REMS) Program is a program intended to lessen the risk of vision loss caused by treatment with vigabatrin (Sabril, Vigadone).
The Vigabatrin REMS program requires those prescribing, dispensing and receiving this medication to enroll in the program and comply with certain requirements.